About the Journal

Focus and Scope

The journal includes various fields of pharmaceuticals sciences such as:
-Pharmacology and Toxicology
-Pharmacokinetics
-Community and Clinical Pharmacy
-Pharmaceutical Chemistry
-Pharmaceutical Biology
-Pharmaceutics
-Pharmaceutical Technology
-Biopharmaceutics
-Pharmaceutical Microbiology and Biotechnology
-Alternative medicines

OPEN ACCESS POLICY

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

PUBLICATION ETHICS

Statement of Publication Ethics and Malpractice The Benzena Scientific Journal of Pharmacy (BPSJ) is a peer-reviewed national and international journal. This statement clarifies ethical behaviour for all parties involved in the publication of BPSJ manuscripts, including authors, editors-in-chief, editorial boards, peer reviewers, and the publisher (Faculty of Pharmacy, University of Pekalongan). This statement is based on practice guidelines for publication, such as the best practices of the Committee on Publication Ethics (COPE).

Ethical Guideline for Journal Publication
The publication of an article in the peer-reviewed Benzena Pharmaceutical Scientific Journal is an essential building block in the development of a coherent and respected network of knowledge. It is a direct reflection of the quality of the work of the authors and the institutions that support them. Peer-reviewed articles support and embody the scientific method. It is, therefore, important to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher, and the society.

The Faculty of Pharmacy, Pekalongan University, Indonesia, as the publisher of Benzena Pharmaceutical Scientific Journal, takes its duties of guardianship over all stages of publishing extremely seriously, and we recognize our ethical and other responsibilities. We are committed to ensuring that advertising, reprint, or other commercial revenue has no impact or influence on editorial decisions. In addition, the Faculty of Pharmacy, Pekalongan University, and the Editorial Board will assist in communications with other journals and/or publishers where this is useful and necessary..

Publication decisions
The editor of the Benzena Pharmaceutical Scientific Journal (BPSJ) is responsible for deciding which of the articles submitted to the journal should be published. The validation of the work and its importance to researchers and readers must always be the primary considerations in making such decisions. The editors are guided by the policies of the journal's editorial board and are bound by legal requirements regarding libel, copyright infringement, and plagiarism. Furthermore, the editors may consult with other editors or reviewers during the decision-making process. The journal utilizes the Turnitin Plagiarism Scanner to detect potential plagiarism in all manuscripts.

Fair play
An editor at any time evaluates manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

Confidentiality
The editor and any editorial board member must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, other editorial advisers, and the publisher, as appropriate.

Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

DUTIES OF REVIEWERS
Contribution to Editorial Decisions
Reviewer(s) assists the editorial team in making editorial decisions and through the editorial communications with the author. Besides, the reviewer(s) may also assist the author in improving the paper.

Promptness
Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor and excuse himself from the review process.

Confidentiality
Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorized by the editor.

Standards of Objectivity
Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

Acknowledgment of Sources
Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

Disclosure and Conflict of Interest
Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

DUTIES OF AUTHORS
Reporting standards
Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical conduct and are unacceptable.

Originality and Plagiarism
The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication
An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing conduct and is unacceptable.

Acknowledgment of Sources
Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work.

Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Hazards and Human or Animal Subjects
If the work involves chemicals, procedures, or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. The procedures related to humans or animals should be approved by the Ethics Committee and/or refer to the standard procedures.

Natural Medicine Materials
A study using natural medicine materials should provide the latin names, nomenclature author, family name (in parentheses), the source, extraction/fractionation methods for all collected materials used in the study. Pharmacological Evaluation of the materials should use a reference (positive control).

Disclosure and Conflicts of Interest
All authors should disclose in their manuscript any financial or another substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

Fundamental errors in published works
When an author discovers a significant error or inaccuracy in his/her own published work, it is the author’s obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper

PUBLICATION FREQUENCY

Benzena Pharmaceutical Scientific Journal (BPSJ) is a peer-reviewed journal published twice a year (January–June and July–December).

DIGITAL ARCHIVING

This journal utilizes the Open Journal Systems (OJS), Indonesian Scientific Journal Database (ISJD), and Indonesian Publication Index (IPI) system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration.

Indexing and Abtracting

Benzena Pharmaceutical Scientific Journal is Indexed by:

1. Google Scholar

2. Crossreff

3. Garuda

4. Dimensions

5. Base

6. Cite Factor

7. PKP Index

 

Editorial Policies

The Benzena Pharmaceutical Scientific Journal’s editorial policies regarding scientific research publications can be reviewed below.

Peer-Review Process
This journal uses a double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process.

Rapid Peer-Review Process
The Benzena Pharmaceutical Scientific Journal does not accept requests for the rapid peer-review process at all. All manuscripts submitted to the Benzena Pharmaceutical Scientific Journal will be treated the same as described in the peer-review process section.

Authorship of the Paper
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

Disclosure and conflicts of interest
Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author.

Informed Consent
For research related to human subjects, the investigators must ask for the consent of the candidate subject through informed consent and the procedure must be conveyed in the research protocol submitted to the research ethics committee. With the approval of the research protocol by the ethics committee, the informed consent procedure was also approved. However, the authors must be able to provide evidence documents of the subjects' informed consent when requested by the editorial board for clarification at any time.

Hazards and Human or Animal Subjects
The procedures related to humans or animals should be approved by the Ethics Committee and/or refer to the standard procedures, and evidenced by a statement in the manuscript informing the name of the institution/research ethics committee and the ethic number obtained. If the work involves chemicals, procedures, or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the author could not provide it, the Benzena Pharmaceutical Scientific Journal will decline submission.

Data Sharing and Retention
Authors are asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should, in any event, be prepared to retain such data for a reasonable time after publication.

Presubmission Inquiry
The Benzena Pharmaceutical Scientific Journal only accepts pre-submission inquiries via email to jurnalbenzenaunikal@gmail.com with the subject title "Presubmission Inquiry".

No Prior Publication
The Benzena Pharmaceutical Scientific Journal only accepts publication manuscripts that have never been submitted to and/or published in other journals or proceedings.

Scientific Meetings
In the event of a scientific meeting in collaboration with Benzena Pharmaceutical Scientific Journal, the peer-review process will still be carried out by the Benzena Pharmaceutical Scientific Journal and will be treated the same as described in the peer-review process section (no rapid peer-review process).

Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Copyrights / Permissions
For all articles published in Benzena Pharmaceutical Scientific Journal, the copyright is retained by the journal. Articles are published under the terms of the Creative Commons Attribution License. The CC-BY license permits redistribute and copy the article in any format or medium, as well as transform, remix, and build upon the material for any purposes. Attribution must be given to articles published in this journal, including providing appropriate credits, links, and indication if changes are made.

For Authors:

  • The Author grants the journal, the rights of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the authors and initial publications in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
  • The article and any associated published material is distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.

Information For Readers

We encourage readers to sign up for the publishing notification service for this journal. Use the Register link at the top of the home page for the journal. This registration will result in the reader receiving the Table of Contents by email for each new issue of the journal. This list also allows the journal to claim a certain level of support or readership. See the journal's Privacy Statement, which assures readers that their name and email address will not be used for other purposes.

 

Are you interested in submitting to this journal? We recommend that you review the About the Journal page for the journal's section policies, as well as the Author Guidelines. Authors need to register with the journal before submitting or, if already registered, can log in and begin the five-step process.